Sun Pharma gets FDA observation for Baska plant

Sun Pharma gets FDA observation for Baska plant
Highlights

New Delhi: Drug major Sun Pharma on Monday said it has received one observation from the US health regulator...

New Delhi: Drug major Sun Pharma on Monday said it has received one observation from the US health regulator for its Baska manufacturing facility in Gujarat.

In a regulatory filing, the Mumbai-based company said the US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) of Baska facility from January 28 to February 5, 2019.

"At the conclusion of the inspection, the USFDA issued a Form 483, with one observation for which the company has submitted the response," it added.

Show Full Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
More Stories


Top